Print

Largest Chinese CRO, WuXi PharmaTech Co., Ltd., Purchases Multiyear ADMET Predictor License  
11/12/2013 8:47:28 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

LANCASTER, Calif.--(BUSINESS WIRE)--Simulations Plus, Inc. (NASDAQ: SLP), a leading provider of consulting services and software for pharmaceutical discovery and development, today announced that WuXi PharmaTech (NYSE:WX), China’s largest contract research organization (CRO), has obtained a multiyear license to ADMET Predictor™, Simulations Plus’ flagship structure-to-property prediction software.

Help employers find you! Check out all the jobs and post your resume.

//-->